
Mergers and Acquisitions in the IVD Market
Description
Mergers and Acquisitions in the IVD Market
In vitro diagnostic (IVD) products continue to see positive sales growth in many categories. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture. In this environment, companies are making strategic acquisitions that simultaneously add a revenue stream and product innovation. Kalorama Information looks at these market transactions in Mergers and Acquisitions in the IVD Market, recording more than 220 acquisitions in the diagnostics industry from 2016 to June 2019.
Though some segments of the overall IVD market are still relatively small, they represent the biggest growth areas in the market. The report focuses on acquisitions in these growing segments of great market interest, anticipated to be a big part of the future of IVD, including the following:
In vitro diagnostic (IVD) products continue to see positive sales growth in many categories. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture. In this environment, companies are making strategic acquisitions that simultaneously add a revenue stream and product innovation. Kalorama Information looks at these market transactions in Mergers and Acquisitions in the IVD Market, recording more than 220 acquisitions in the diagnostics industry from 2016 to June 2019.
Though some segments of the overall IVD market are still relatively small, they represent the biggest growth areas in the market. The report focuses on acquisitions in these growing segments of great market interest, anticipated to be a big part of the future of IVD, including the following:
- Next-Generation Sequencing (NGS)
- Cancer Testing (Liquid Biopsy)
- Companion Diagnostics
- Roche
- Abbott
- Danaher
- Selected Acquisitions of Diagnostic Companies, from 2018 to end June 2019
- Selected Acquisitions of Diagnostic Companies, 2016-2017
- Danaher / Beckman Coulter Acquisitions in 2018 / 2019
- QIAGEN M&A Activity
- bioMérieux Activity in M&A
- Illumina Acquisitions of PacBio, Edico Genome
- Abbott’s Acquisitions, Divestures and the Alere Deal
- Siemens’ M&A Activity in Recent Years
- Konica Minolta’s Acquisitions of Ambry Genetics and Invicro, Building a Presence in Precision Medicine
- Thermo’s Completion of the Patheon Acquisition
- Danaher’s Acquisition of Molecular Diagnostics Leader Cepheid for Nearly $4 Billion
Table of Contents
03 Pages
- The Market Landscape
- Mergers and Acquisitions of Some Major Market Players
- Mergers and Acquisitions across Various Market Segments
- Methodology
- Brief Overview: The IVD Industry
- Selected 2018 / 2019 Acquisitions of Note
- Selected 2016 / 2017 Acquisitions of Note
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.